{"id":"W3017396921","doi":"10.1111/apt.15719","title":"Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Crohn's disease; Infliximab; Adalimumab; Ustekinumab; Internal medicine; Vedolizumab; Refractory (planetary science); Golimumab; Concomitant; Clinical trial; Maintenance therapy; Surgery; Gastroenterology; Cohort; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005338746,0.0001876937,0.0001632488,0.00003269274,0.00005415842,0.000003474162,0.0001339424,0.00006093199,0.00008063792],"category_scores_gemma":[6.742787e-7,0.000153703,0.00003763793,0.00006717941,0.0002867756,0.000004728407,0.00005965883,0.00007781053,0.000004306807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000378146,"about_ca_system_score_gemma":0.0001467581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001075905,"about_ca_topic_score_gemma":0.0000196467,"domain_scores_codex":[0.9989832,0.000172557,0.0002343946,0.0003308998,0.00007592247,0.0002030276],"domain_scores_gemma":[0.9994317,0.00006740401,0.00009843528,0.0001688063,0.00003252357,0.000201154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02416048,0.001560992,0.09838611,0.00005281087,0.005702659,0.001201654,0.0008183991,0.002437084,0.8603342,0.00002522339,0.00007251371,0.005247923],"study_design_scores_gemma":[0.06921725,0.01053693,0.6293106,0.00007618278,0.01946205,0.00005211341,0.0009315611,0.00750386,0.2013911,0.00008397791,0.05937866,0.002055708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959354,0.001833186,0.00003716047,0.001426362,0.00005766761,0.0005436465,0.0001067223,0.00001502666,0.00004476212],"genre_scores_gemma":[0.9894668,0.002217853,0.0001628434,0.007756966,0.0001019383,0.00004635505,0.0002067511,0.00001989454,0.00002054591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6589431,"threshold_uncertainty_score":0.6267828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01796199513324832,"score_gpt":0.3002074370836827,"score_spread":0.2822454419504344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}